Drug Trial Radar · NCT04713475
Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis
Last checked: Nov 19, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
26
Planned (sponsor's estimate)
Start
Mar 17, 2021
Primary completion
Feb 2028
Study completion Feb 2029
Sponsor
- Lead sponsor
- Gemma BiotherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 19, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 month, up to 24 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PBGM01 is a gene therapy for GM1 gangliosidosis intended to deliver a functional copy of the GLB1 gene to the brain and peripheral tissues. This study will assess in a 2 part design the safety, tolerability and efficacy of PBGM01 in patients with early onset infantile (Type 1) and late onset infantile (Type 2a) GM1 gangliosidosis
Conditions
- GM1 Gangliosidosis
- GM1 Gangliosidosis, Type I
- GM1 Gangliosidosis, Type 2
- Beta-Galactosidase-1 (GLB1) Deficiency
Interventions
PBGM01Biological
AAVhu68 viral vector
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment Related AEs and SAEs as Characterized by CTCAEv5.0Time frame: Up to 5 years (multiple visits)
- Change from Baseline in Developmental Milestones as Assessed by the Bayley Scale of Infant and Toddler Development, Third EditionTime frame: From baseline to 2 years (multiple visits)
Locations
7 sites in 4 countries. Site status is shown where the registry gives one.
Benioff Children's Hospital
Oakland, California
University of Minnesota
Minneapolis, Minnesota
Children's Hospital at St. Peter's University Hospital
New Brunswick, New Jersey
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Hospital de Clínicas de Porto Alegre (HCPA)
Porto Alegre, Brazil
Gazi University
Ankara, Turkey (Türkiye)
Great Ormond Street Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.